Your assistance will enable us to persist in uncovering innovative solutions for addressing the unseen effects of combat and dependency on opioids.
RESEARCH CAPABILITIES
A 501C3 Nonprofit Research Organization
Providing Contracted, Outreach, Acquisition, Research & Development, and Consultative Services Supplying FAR & OTA Solutions, Alternatives and NON Traditional contracting opportunities
Our veterans research team is extensive in scale and scope.
American Military Families Action Network operates a VRG (veterans research group)that offers unique perspectives that offer value-added design and operations to the advanced research ecosystem & atmosphere. Our group's capabilities include facilitating the development of underlying infrastructure for organizing, orchestrating, harmonizing, collecting, analyzing, and distributing of mass data sets.
Our relevance includes and is focused on cutting-edge research in health sciences including personalized medicine, regenerative medicine, and artificial intelligence, aimed at revolutionizing medical treatment for military families and beyond.
Research and development group interests:
Global Acquisition Services.
Delivering specialized services in emerging markets, customized to meet the unique needs of each project.
Advancing Healthcare Solutions
Biotechnology is a rapidly developing field of engineering that harnesses living systems to create various technologies and capabilities. Whether it's combating worldwide pandemics, minimizing logistical challenges, or enhancing energy efficiency, biotechnology has the potential to revolutionize how we approach missions, operate in challenging logistics settings, and respond to significant global shifts.
Advancing Health & Science Innovation
Pushing the Boundaries of Possibility Driving progress across various research domains and eliminating barriers that hinder advancements toward solutions. The tools and platforms developed have broad applications across a spectrum of diseases. toward solutions. The tools and platforms developed have broad applications across a spectrum of diseases.
Scaling Solutions Navigating challenges such as geography, distribution, manufacturing, data and information, and economies of scale to devise programs that yield impactful, timely, and equitable solutions.
Natural Sciences, Pharmacy, and Health Professions:
Technology:
Mathematics/Computer Science:
Health Disparities:
Emergency Management:
Brain trauma, PTSD and those injuries akin to CTE resulting from blast force is the predominant injury observed in the Iraq and Afghanistan campaigns, affecting hundreds of thousands of U.S. combat personnel. Despite being invisible, this damage profoundly impacts a soldier's mental and emotional well-being.
Recent studies have highlighted significant comorbidity rates between cannabis use disorders and posttraumatic stress disorder (PTSD) among veterans. However, despite potential connections between PTSD and cannabis use, there is limited understanding of cannabis use among veterans seeking treatment for PTSD, especially among those not diagnosed with a substance use disorder.
ndogenously produced cannabinoids, known as endocannabinoids, along with plant-derived cannabinoids (phytocannabinoids), interact with the Endocannabinoid System via specialized cellular receptors discovered in the 1990s, namely CB1 and CB2 receptors. CB1 receptors are predominantly located in the brain and central nervous system, whereas CB2 receptors are primarily found in the organs and tissues of the immune system, including the thymus, skin, lymph nodes, bone marrow, spleen, colon, and mucous membranes of various body parts such as the sinus, anus, genitals, nose, bladder, and throat. Both types of receptors play a role in processing cannabinoids in different physiological contexts.
An integrated perspective on endocannabinoids (eCBs) and external cannabinoids in the pathophysiology and prospective treatment of PTSD and related conditions. Reduced levels of anandamide (AEA) and/or 2-arachidonoylglycerol (2-AG), either induced by stress or pre-existing due to genetic predispositions, are linked to various detrimental behavioral and physiological outcomes, including heightened vulnerability to developing trauma-related disorders such as PTSD, TBI, and CTE. Therapeutic augmentation of eCBs could potentially reverse these existing deficiencies or stress-induced imbalances through the inhibition of fatty acid amide hydrolase (FAAH) or monoacylglycerol lipase (MAGL) activity, referred to as FAAH inhibition (FAAHi) and MAGL inhibition (MAGLi), respectively.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.